Effects of NG‐nitro‐l‐arginine methyl ester on vasodilator responses to acetylcholine, 5′‐N‐ethylcarboxamidoadenosine or salbutamol in conscious rats
Open Access
- 19 July 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 103 (3) , 1725-1732
- https://doi.org/10.1111/j.1476-5381.1991.tb09854.x
Abstract
1 Conscious, Long Evans rats (n = 16), chronically instrumented for the measurement of regional haemodynamics were given 3min, randomized infusions of two doses of sodium nitroprusside (1.5 and 15 μg min−1), acetylcholine (0.4 and 4 μg min−1), 5′-N-ethylcarboxamidoadenosine (NECA; 45 and 450 ng min−1), and salbutamol (24 and 240 ngmin−1) in the absence and in the presence of NG-nitro-l-arginine methyl ester (l-NAME; 1 mg kg−1 h−1), a potent inhibitor of nitric oxide biosynthesis. 2 Sodium nitroprusside caused hyperaemic vasodilatation in the mesenteric, and common carotid vascular beds. These effects were enhanced in the presence of l-NAME, as was the hypotension. 3 Acetylcholine caused hyperaemic vasodilatation in the renal, internal carotid and common carotid vascular beds. These effects were attenuated in the presence of l-NAME, but the hypotension was unaffected. 4 NECA caused hyperaemic vasodilatation in the renal, mesenteric, hindquarters, internal carotid and common carotid vascular beds. However, only the hindquarters and internal carotid responses were diminished in the presence of l-NAME and the hypotension was unchanged. 5 Salbutamol caused hyperaemic vasodilatation in the hindquarters vascular bed only. This effect was reduced in the presence of l-NAME, but the hypotension was unchanged. 6 The results indicate marked regional variations in the sensitivity of vasodilator responses to l-NAME that can depend on the vasodilator agent chosen and the dose employed. It is clear from these findings also that measurement of mean arterial blood pressure alone cannot provide adequate information on which to judge the involvement of l-NAME-sensitive mechanisms in vasodilator responses in vivo.Keywords
This publication has 34 references indexed in Scilit:
- Endothelium‐derived relaxing factor (EDRF) and nitric oxide (NO). II.Clinical Physiology and Functional Imaging, 1990
- Control of regional blood flow by endothelium-derived nitric oxide.Hypertension, 1990
- What is the relationship between the endothelium derived relaxant factor and nitric oxide?Life Sciences, 1989
- L-arginine availability determines the duration of acetylcholine-induced systemic vasodilatation in vivoBiochemical and Biophysical Research Communications, 1989
- NG-methylarginine, and inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo?Biochemical and Biophysical Research Communications, 1989
- Regional Hemodynamic Effects of Endothelin-1 in Conscious, Unrestrained, Wistar RatsJournal of Cardiovascular Pharmacology, 1989
- Mechanisms Underlying the Inhibitory Interaction Between the Nitrovasodilator SIN-1 and the EndotheliumJournal of Cardiovascular Pharmacology, 1989
- Modulation of the Vasodilator Action of SIN-1 by the EndotheliumJournal of Cardiovascular Pharmacology, 1989
- The discovery of nitric oxide as the endogenous nitrovasodilator.Hypertension, 1988
- Endothelium-Removal Decreases Relaxations of Canine Coronary Arteries Caused by β-Adrenergic Agonists and AdenosineJournal of Cardiovascular Pharmacology, 1985